National Gastrointestinal Cancer Audit Programme

Applications closing date: 13 Nov 2017 00:00

Please note deadline for submissions has now passed

The overarching aim of the National Gastrointestinal Cancer Audit Programme (NGCAP) is to improve the quality of services and patient outcomes for patients newly diagnosed with:

a) bowel cancer, and

b) oesophago-gastric cancer or high grade dysplasia of the oesophagus.

During this contract period, there should be a particular focus on enhancing quality improvement (QI) leadership and the QI focus of the design and delivery of the audit.

The aim will be achieved through a project with the following objectives:

  • identify up to 5 specific health improvement goals for each audit workstream over the contract period;
  • ensure QI expertise is available to support the central audit project team from design through to delivery of all outputs;
  • utilise strong and effective project and programme management to deliver audit outputs on time and within budget;
  • collect and analyse data along the patient pathway which:
    a) are closely aligned with national standards and guidelines,
    b) utilize mandated data flows and linkages to reduce or remove the requirement for bespoke audit data items to reduce the burden on the service/duplication of effort, and
    c) provide data which can be used to reduce variation and improve care processes and patient outcomes;
  • identify the key audiences targeted to achieve the improvement goals; ensure that the narrative of all reports and other outputs clearly links the improvement goals and associated findings with specific and targeted recommendations by audience. Audiences are described in HQIP’s Reporting For Impact Guidance ;
  • continually improve timeliness and accessibility of outputs;
    engage patients, carers and families in a meaningful way, achieving a strong patient voice which informs and contributes to the design, functioning, outputs and direction of the audit;
  • continually strengthen the audit’s engagement with local clinicians, networks, commissioners, patients and their families and carers, and charity and community support groups in order to enhance the uses of the data for improvement;
  • effectively integrate into one audit programme the oesophago-gastric and bowel cancer audit workstreams.